Hypertension Prevention
Scientists at Cardiff University, Wales Heart Research Institute describe research in hypertension prevention
Published in Drug Week, September 28th, 2007
A new study, "The vasodilatory beta-blockers," is now available. "Although well established in treating hypertension and cardiovascular (CV) disease, clinical trial data suggest that beta-blockers (eg, atenolol) may be less effective than other antihypertensive classes in reducing stroke and CV mortality despite similar blood pressure (BP) reductions. One possible explanation is that atenolol is less effective in reducing central aortic pressure," investigators in Cardiff, the United Kingdom report.
"Newer vasodilating beta-blockers may prove more effective in reducing central pressure and cardiovascular events. Carvedilol and labetalol appear to cause vasodilation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-09-28)
More Articles from Drug Week
- Adverse Drug Reactions
Study shows adverse drug events reported to the FDA have significantly increased - Arthritis
Study identifies genetic risk factor for rheumatoid arthritis, lupus - Biomedicine
Study Sheds Light on Role of Vitamin E in Heart Disease Prevention - Blood Safety
Scientists, physicians present latest findings in 'personalized' cancer treatment and prevention - Boston University
BUSM, BMC adopt strict policy on interactions between clinicians and industry - Breast Cancer
New clues to breast cancer development in high-risk women - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
